Announcements
6 May 2025
World Asthma Day—“Make Inhaled Treatments Accessible for All”, 6 May 2025
World Asthma Day is held on the first Tuesday in May, aiming to improve asthma awareness and care around the world. World Asthma Day is organized by the Global Initiative for Asthma (GINA), a World Health Organization collaborative organization founded in 1993. In celebration of World Asthma Day 2025, GINA has chosen the theme “Make Inhaled Treatments Accessible for All”. GINA emphasizes the need to ensure that people with asthma can access inhaled medications that are essential both for controlling the underlying disease and treating attacks.
Asthma is one of the most common chronic non-communicable diseases that affects over 260 million people and is responsible for over 450,000 deaths each year worldwide. Most of these deaths are preventable. Inhaled corticosteroid-containing medications prevent asthma attacks by treating the underlying inflammation that causes asthma. Doctors and allied health care professionals are called upon to ensure that every person with asthma is prescribed evidence-based, essential, inhaled corticosteroid-containing medication in addition to (or in combination with) reliever medication, to prevent the continuing but avoidable morbidity and mortality from asthma.
In celebration of this day, we invite you to explore a curation of insightful articles, journals, and Special Issues across various fields, including human diseases and conditions, human nutrition, children’s health, and personalized medicine. By sharing these findings, we hope to call on everyone to increase our efforts in managing asthma to reduce and prevent attacks.
|
|
|
|
|
|
|
|
|
“Burden and Economic Impact of Respiratory Viral Infections in Adults Aged 60 and Older: A Focus on RSV”
by Adrián Peláez, Sara Jimeno Ruiz, Mercedes Villarreal, Manuel Gil, Inés Gutiérrez, Marta Sanz and Silvina Natalini Martínez
Diseases 2025, 13(2), 35; https://doi.org/10.3390/diseases13020035
“Long-Term Greenness Effects of Urban Forests to Reduce PM10 Concentration: Does the Impact Benefit the Population Vulnerable to Asthma?”
by Jinsuk Jeong, Chaewan Kim, Sumin Choi, Hong-Duck Sou and Chan-Ryul Park
Int. J. Environ. Res. Public Health 2025, 22(2), 167; https://doi.org/10.3390/ijerph22020167
“Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A “Real-Life” Observational Study”
by Eugenio De Corso, Dario Antonio Mele, Angela Rizzi, Camilla Spanu, Marco Corbò, Serena Pisciottano, Rodolfo Francesco Mastrapasqua, Silvia Baroni, Davide Paolo Porru, Gabriele De Maio et al.
J. Pers. Med. 2024, 14(9), 1014; https://doi.org/10.3390/jpm14091014
“Current Challenges in Pediatric Asthma”
by Andrija Miculinić, Iva Mrkić Kobal, Tin Kušan, Mirjana Turkalj and Davor Plavec
Children 2024, 11(6), 632; https://doi.org/10.3390/children11060632
“Prediction of Asthma Exacerbations in Children”
by Evangelia Sarikloglou, Sotirios Fouzas and Emmanouil Paraskakis
J. Pers. Med. 2024, 14(1), 20; https://doi.org/10.3390/jpm14010020
“Characterization and Factors Associated with Poor Asthma Control in Adults with Severe Eosinophilic Asthma”
by Clara Padró-Casas, María Basagaña, María Luisa Rivera-Ortún, Ignasi García-Olivé, Carlos Pollan-Guisasola, Aina Teniente-Serra, Eva Martínez-Cáceres, José-Tomás Navarro, Jorge Abad-Capa, Antoni Rosell et al.
J. Pers. Med. 2023, 13(7), 1173; https://doi.org/10.3390/jpm13071173
“Association between Single Nucleotide Polymorphisms Related to Vitamin D Metabolism and the Risk of Developing Asthma”
by Susana Rojo-Tolosa, Laura Elena Pineda-Lancheros, José María Gálvez-Navas, José Antonio Sánchez-Martínez, María Victoria González-Gutiérrez, Andrea Fernández-Alonso, Concepción Morales-García, Alberto Jiménez-Morales and Cristina Pérez-Ramírez
Nutrients 2023, 15(4), 823; https://doi.org/10.3390/nu15040823
“Racial Disparities and Common Respiratory Infectious Diseases in Children of the United States: A Systematic Review and Meta-Analysis”
by Elizabeth A. K. Jones, Amal K. Mitra and Shelia Malone
Diseases 2023, 11(1), 23; https://doi.org/10.3390/diseases11010023
“Microbiome and Asthma: Microbial Dysbiosis and the Origins, Phenotypes, Persistence, and Severity of Asthma”
by José Valverde-Molina and Luis García-Marcos
Nutrients 2023, 15(3), 486; https://doi.org/10.3390/nu15030486
“Effect of Disease Severity, Age of Child, and Clinic No-Shows on Unscheduled Healthcare Use for Childhood Asthma at an Academic Medical Center”
by Pavani Rangachari, Imran Parvez, Audrey-Ann LaFontaine, Christopher Mejias, Fahim Thawer, Jie Chen, Niharika Pathak and Renuka Mehta
Int. J. Environ. Res. Public Health 2023, 20(2), 1508; https://doi.org/10.3390/ijerph20021508
|
“Pulmonary Function in Children with Respiratory Symptoms” |
“Mechanisms of Airway Inflammation in Asthma” |
 |
 |
